About

About

IONETIX is a pioneering radiopharmaceutical end-to-end solution provider.

Founded in 2009 from technology born at MIT Plasma Science and Fusion Center, IONETIX developed the world’s first commercial compact superconducting cyclotron, the ION-12SC used to produce N-13 Ammonia, one of the most accurate PET imaging agents for the detection of CAD.1

IONETIX is actively establishing a network of ION-12SCs installed on or near the campus of PET programs across the country. By covering all costs related to the installation and ongoing operation of the cyclotron and making N-13 Ammonia available to providers through a pay-by-the-dose model, we are making this critical tracer accessible and affordable to providers nationwide.

More recently, IONETIX is leveraging its growing network of radiopharmaceutical manufacturing locations to support the development and commercialization of targeted alpha therapy (TAT). An emerging cancer therapy utilizing alpha radionuclides, TAT delivers high-energy alpha particles to cancer cells and the tumor microenvironment to treat cancer while preserving healthy tissue.

1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382649

OUR QUALITY POLICY

We are committed to the design, manufacturing, and support of safe and effective radiopharmaceutical products which meet or exceed the expectations of customers, medical professionals, users, and applicable regulations and standards.

We are committed to the design, manufacturing, and support of safe and effective radiopharmaceutical products which meet or exceed the expectations of customers, medical professionals, users, and applicable regulations and standards.

Learn about Cardiac PET

Meet our Management Team

Kevin J. Cameron
Kevin J. Cameron
CHIEF EXECUTIVE OFFICER
Anthony Stagnolia
Anthony Stagnolia
CHIEF OPERATIONS OFFICER
John Vincent
John Vincent
VP, ENGINEERING & NEW PRODUCT DEVELOPMENT
David Eve
David Eve
VP, MEDICAL AFFAIRS
Peter Burke
Peter Burke
VP, SALES & MARKETING

Why IONETIX Turnkey Solution?

We’ve created a first-of-its-kind model that eliminates the expense and effort of launching a Cardiac PET program while helping you establish a brand-differentiating service that keeps patients close and drives referrals.

IONETIX Turnkey solution
Learn more about N-13 Ammonia

Scientific Partnerships, Support & Sponsorships

Ready to elevate your Cardiac PET imaging program?

The time is now to establish a brand-differentiating service that keeps patients close and drives referrals.

Contact us